EP3119764 - ANTIFUNGAL COMPOUND PROCESS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 21.02.2020 Database last updated on 02.09.2024 | |
Former | The patent has been granted Status updated on 15.03.2019 | ||
Former | Grant of patent is intended Status updated on 01.10.2018 | ||
Former | Examination is in progress Status updated on 20.04.2018 | ||
Former | Request for examination was made Status updated on 23.12.2016 | ||
Former | The international publication has been made Status updated on 30.11.2016 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Mycovia Pharmaceuticals, Inc. 4505 Emperor Boulevard Suite 300 Durham NC 27703 / US | For all designated states The U.S.A. as represented by the Secretary, Department of Health and Human Services Office of Technology Transfer 6011 Executive Boulevard, Suite 325 Rockville, MD 20852 / US | [2019/28] |
Former [2018/09] | For all designated states Viamet Pharmaceuticals (NC), Inc. 4505 Emperor Boulevard, Suite 300 Durham, NC 27703 / US | ||
For all designated states The U.S.A. as represented by the Secretary, Department of Health and Human Services Office of Technology Transfer 6011 Executive Boulevard, Suite 325 Rockville, MD 20852 / US | |||
Former [2017/04] | For all designated states Viamet Pharmaceuticals, Inc. 4505 Emperor Boulevard, Suite 300 Durham, NC 27703 / US | ||
For all designated states The U.S.A. as represented by the Secretary, Department of Health and Human Services Office of Technology Transfer 6011 Executive Boulevard, Suite 325 Rockville, MD 20852 / US | Inventor(s) | 01 /
HOEKSTRA, William, J. 7 Treviso Place Durham, NC 27707 / US | 02 /
YATES, Christopher, M. 6201 Therfield Drive Raleigh, NC 27614 / US | 03 /
BEHNKE, Mark 20300 White Ferry Road Poolesville, MD 20837 / US | 04 /
ALIMARDANOV, Asaf 5405 Tuckerman Lane Apt. 718 North Bethesda, MD 20852 / US | 05 /
DAVID, Scott, A. 11995 Hunt Road Huntsburg, OH 44046 / US | 06 /
FRY, Douglas, Franklin 130 E. 212th Street Euclid, OH / US | [2017/12] |
Former [2017/04] | 01 /
HOEKSTRA, William, J. 7 Treviso Place Durham, NC 27707 / UY | ||
02 /
YATES, Christopher, M. 6201 Therfield Drive Raleigh, NC 27614 / US | |||
03 /
BEHNKE, Mark 20300 White Ferry Road Poolesville, MD 20837 / US | |||
04 /
ALIMARDANOV, Asaf 5405 Tuckerman Lane Apt. 718 North Bethesda, MD 20852 / US | |||
05 /
DAVID, Scott, A. 11995 Hunt Road Huntsburg, OH 44046 / US | |||
06 /
FRY, Douglas, Franklin 130 E. 212th Street Euclid, OH / US | Representative(s) | Adam, Holger Kraus & Weisert Patentanwälte PartGmbB Thomas-Wimmer-Ring 15 80539 München / DE | [2017/04] | Application number, filing date | 15764654.8 | 19.03.2015 | [2017/04] | WO2015US21476 | Priority number, date | US201461955568P | 19.03.2014 Original published format: US 201461955568 P | [2017/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015143162 | Date: | 24.09.2015 | Language: | EN | [2015/38] | Type: | A1 Application with search report | No.: | EP3119764 | Date: | 25.01.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.09.2015 takes the place of the publication of the European patent application. | [2017/04] | Type: | B1 Patent specification | No.: | EP3119764 | Date: | 17.04.2019 | Language: | EN | [2019/16] | Search report(s) | International search report - published on: | KR | 24.09.2015 | (Supplementary) European search report - dispatched on: | EP | 03.07.2017 | Classification | IPC: | C07D213/84, C07D213/38, C07D401/06, A61K31/41, A61K31/4439, A61P31/04 | [2017/31] | CPC: |
C07D401/06 (EP,US);
A61P31/04 (EP);
C07D213/38 (EP,US);
C07D213/84 (EP,US)
|
Former IPC [2017/04] | C07D403/06, C07D401/06, C07D257/04, C07D295/215, A61K31/41, A61K31/4439, A61P31/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/04] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | VERFAHREN FÜR FUNGIZIDE VERBINDUNG | [2017/04] | English: | ANTIFUNGAL COMPOUND PROCESS | [2017/04] | French: | PROCÉDÉ DE PRÉPARATION D'UN COMPOSÉ ANTIFONGIQUE | [2017/04] | Entry into regional phase | 15.09.2016 | National basic fee paid | 15.09.2016 | Search fee paid | 15.09.2016 | Designation fee(s) paid | 15.09.2016 | Examination fee paid | Examination procedure | 15.09.2016 | Examination requested [2017/04] | 15.09.2016 | Date on which the examining division has become responsible | 29.01.2018 | Amendment by applicant (claims and/or description) | 20.04.2018 | Despatch of a communication from the examining division (Time limit: M04) | 20.08.2018 | Reply to a communication from the examining division | 02.10.2018 | Communication of intention to grant the patent | 12.02.2019 | Fee for grant paid | 12.02.2019 | Fee for publishing/printing paid | 12.02.2019 | Receipt of the translation of the claim(s) | Opposition(s) | 20.01.2020 | No opposition filed within time limit [2020/13] | Fees paid | Renewal fee | 27.03.2017 | Renewal fee patent year 03 | 27.03.2018 | Renewal fee patent year 04 | 08.03.2019 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 19.03.2015 | AL | 17.04.2019 | AT | 17.04.2019 | CY | 17.04.2019 | CZ | 17.04.2019 | DK | 17.04.2019 | EE | 17.04.2019 | ES | 17.04.2019 | FI | 17.04.2019 | HR | 17.04.2019 | LT | 17.04.2019 | LV | 17.04.2019 | MC | 17.04.2019 | MK | 17.04.2019 | MT | 17.04.2019 | NL | 17.04.2019 | PL | 17.04.2019 | RO | 17.04.2019 | RS | 17.04.2019 | SE | 17.04.2019 | SI | 17.04.2019 | SK | 17.04.2019 | SM | 17.04.2019 | TR | 17.04.2019 | BG | 17.07.2019 | NO | 17.07.2019 | GR | 18.07.2019 | IS | 17.08.2019 | PT | 17.08.2019 | [2022/32] |
Former [2022/28] | HU | 19.03.2015 | |
AL | 17.04.2019 | ||
AT | 17.04.2019 | ||
CY | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
MT | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SI | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/50] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
MC | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SI | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/26] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SI | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/17] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
TR | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/14] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SK | 17.04.2019 | ||
SM | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/11] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
EE | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
SK | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/10] | AL | 17.04.2019 | |
AT | 17.04.2019 | ||
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RO | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/09] | AL | 17.04.2019 | |
CZ | 17.04.2019 | ||
DK | 17.04.2019 | ||
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2020/04] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
IS | 17.08.2019 | ||
PT | 17.08.2019 | ||
Former [2019/52] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
PL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/51] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
BG | 17.07.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/50] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
LV | 17.04.2019 | ||
NL | 17.04.2019 | ||
RS | 17.04.2019 | ||
SE | 17.04.2019 | ||
NO | 17.07.2019 | ||
GR | 18.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/49] | AL | 17.04.2019 | |
ES | 17.04.2019 | ||
FI | 17.04.2019 | ||
HR | 17.04.2019 | ||
LT | 17.04.2019 | ||
NL | 17.04.2019 | ||
SE | 17.04.2019 | ||
NO | 17.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/48] | ES | 17.04.2019 | |
FI | 17.04.2019 | ||
LT | 17.04.2019 | ||
NL | 17.04.2019 | ||
SE | 17.04.2019 | ||
NO | 17.07.2019 | ||
PT | 17.08.2019 | ||
Former [2019/47] | ES | 17.04.2019 | |
FI | 17.04.2019 | ||
LT | 17.04.2019 | ||
NL | 17.04.2019 | ||
NO | 17.07.2019 | ||
Former [2019/44] | NL | 17.04.2019 | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [A]WO2011133875 (VIAMET PHARMACEUTICALS INC [US], et al) [A] 1-37 * See the whole document *; | [A]WO2013109998 (VIAMET PHARMACEUTICALS INC [US]) [A] 1-37 * See the whole document *; | [A]WO2013110002 (VIAMET PHARMACEUTICALS INC [US]) [A] 1-37* See the whole document * |